Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,670.00
-50.60 (-2.94%)
Mar 28, 2025, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 175.82 billion as of March 31, 2025. Its market cap has increased by 16.21% in one year.
Market Cap
175.82B
Enterprise Value
173.01B
Revenue
10.89B
Ranking
n/a
PE Ratio
53.88
Stock Price
1,670.00
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 175.82B, an increase of 78.26%. That is a compound annual growth rate of 43.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 175.82B | -23.98% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,162.13B |
| Divi's Laboratories | 1,533.20B |
| Cipla | 1,164.75B |
| Mankind Pharma | 1,000.40B |
| Apollo Hospitals Enterprise | 951.31B |
| Zydus Lifesciences | 891.93B |
| Aurobindo Pharma | 674.02B |
| Alkem Laboratories | 583.68B |